ROSUVASTATIN - MEDO 40 MG

Land: Ísrael

Tungumál: enska

Heimild: Ministry of Health

Virkt innihaldsefni:

ROSUVASTATIN AS CALCIUM

Fáanlegur frá:

A.L. MEDI-MARKET LTD.

ATC númer:

C10AA07

Lyfjaform:

FILM COATED TABLETS

Samsetning:

ROSUVASTATIN AS CALCIUM 40 MG

Stjórnsýsluleið:

PER OS

Gerð lyfseðils:

Required

Framleitt af:

MEDOCHEMIE LTD – FACTORY AZ, CYPRUS

Lækningarsvæði:

ROSUVASTATIN

Ábendingar:

Treatment of adults with: Primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia)or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other nonpharmacological treatments (e.g. exercise weight reduction ) is inadequate.Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments(e.g. LDL apheresis) or if such treatments are not appropriate.

Leyfisdagur:

2021-02-15

Upplýsingar fylgiseðill

Page 1 of 8
PATIENT PACKAGE INSERT IN ACCORDANCE WITH
THE PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986
This medicine is dispensed with a doctor’s prescription only
Rosuvastatin-Medo 5 mg
Rosuvastatin-Medo 10 mg
Film-coated tablets
Film-coated tablets
Rosuvastatin-Medo 20 mg
Rosuvastatin-Medo 40 mg
Film-coated tablets
Film-coated tablets
Composition:
Each tablet contains:
Rosuvastatin 5 mg
Rosuvastatin 10 mg
(as rosuvastatin calcium)
(as rosuvastatin calcium)
Rosuvastatin 20 mg
Rosuvastatin 40 mg
(as rosuvastatin calcium)
(as rosuvastatin calcium)
For inactive ingredients
and allergens, please see Section 2 - “Important information about
some of the ingredients in this medicine” and Section 6 -
“Additional Information”.
Read the leaflet carefully in its entirety before using the medicine.
This leaflet contains concise information about the medicine. If you
have further questions, refer
to the doctor or pharmacist.
This medicine has been prescribed to treat your illness. Do not pass
it on to others. It may harm
them, even if it seems to you that their illness is similar.
Rosuvastatin-Medo is not intended for children and adolescents under
the age of 18.
1.WHAT IS THE MEDICINE INTENDED FOR?
Rosuvastatin-Medo is indicated for treatment of adults with:
•
primary hypercholesterolemia (type IIa including heterozygous familial
hypercholesterolemia)
(conditions when the blood cholesterol level is high) or type IIb
mixed dyslipidemia (a
disorder in the level of various blood lipids). The medicine is given
as an adjunct to diet when
response to diet and other non-pharmacological treatments (e.g.
exercise weight reduction)
is inadequate
•
homozygous familial hypercholesterolemia (conditions when the blood
cholesterol level is
high) as an adjunct to diet and other lipid lowering treatments (e.g.
LDL apheresis) or if such
treatments are not appropriate.
Therapeutic group
HMG-CoA reductase enzyme inhibitor
Rosuvastatin-Medo belongs to a class of medicines called statins,
which works by reducing fat levels
in